SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst intense community debate following former President Trump's proposal to impose tariffs on European nations unless Greenland is ceded to the United States. Supporters tout this as a strategic move for national security and Arctic dominance, while critics express concern over potential market instability, diplomatic fallout with NATO allies, and broader geopolitical tensions. The discussions highlight significant divisions regarding trade policy and international relations.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending due to forecasts of an intensifying and widespread cold snap across the US, potentially extending into February. This has sparked widespread community discussion about a significant short squeeze, given the commodity's high short interest and anticipated heating demand, alongside concerns about the inherent volatility and decay of leveraged natural gas products.

Materion Corp. engages in the production of engineered materials used in a variety of electrical, electronic, thermal, and structural applications. It operates through the following segments: Performance Materials, Electronic Materials, Precision Optics, and Other. The Performance Materials segment provides engineered solutions consisting of beryllium and non-beryllium. The Electronic Materials segment produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products. The Precision Optics segment designs and produces precision thin film coatings, optical filters, and assemblies. The Other segment includes unallocated corporate costs and assets. The company was founded in 1931 and is headquartered in Mayfield Heights, OH.

Materion Corp

Materion (MTRN) is attracting significant attention following recent strong quarterly performance and multiple analyst upgrades, underscoring its operational strength. The community is actively discussing Materion's strategic investments in advanced materials, critical for high-growth sectors like semiconductors, aerospace, and artificial intelligence, suggesting optimism for its future trajectory and perceived undervaluation.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following strategic pipeline expansion through recent acquisitions and a key collaboration with Abbott for its Phase 3-ready anticoagulant, tecarfarin. This drug, holding Orphan Drug and Fast Track designations, is generating discussion among investors bullish on its market potential, even as a vocal segment of the community raises concerns about alleged bot activity, past dilutions, and the company's need for capital.

First Interstate BancSystem, Inc. is a financial holding company, which provides community banking solutions. The firm offers commercial and consumer banking services to individuals, businesses, municipalities, and other entities. The company was founded by Homer Scott Sr. in 1968 and is headquartered in Billings, MT.

First Interstate BancSystem Inc.

First Interstate BancSystem Inc. - Ordinary Shares - Class A

First Interstate BancSystem (FIBK) is trending amid activist investor pressure from HoldCo Asset Management, urging a strategic pivot to share buybacks over acquisitions following past underperformance. The community is actively discussing the new CEO's focus on organic growth and branch optimization, with some analysts upgrading the stock and insider buying adding to investor interest, despite mixed broader analyst sentiment.

China Yuchai International Ltd. is a holding company, which engages in the manufacture, assembly, and sale of light, medium, and heavy-duty engines for trucks, buses, passenger vehicles, construction equipment, marine, and agriculture applications. It operates through Yuchai and HL Global Enterprises Limited (HLGE) segments. The Yuchai segment conducts manufacturing for on- and off-road powertrain solutions and applications which are mainly distributed in the PRC market. The HLGE segment includes hospitality and property development activities conducted mainly in the PRC and Malaysia. The company was founded on April 29, 1993 and is headquartered in Singapore.

China Yuchai International

China Yuchai International is trending following recent news of a significant stake acquisition and positive analyst coverage, alongside reports of strong financial results and strategic expansion into hydrogen fuel cell technology for commercial vehicles. The community views CYD as a deeply undervalued "gem," citing its substantial cash reserves and low valuation, while noting growing institutional interest amid China's broader market dynamics and the surging demand from the data center sector.

APi Group Corp. engages in the provision of life safety and specialty services. It operates through the Safety Services and Specialty Services segments. The Safety Services segments offers safety services in North America and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, HVAC, and entry systems), including design, installation, inspection, and service of these integrated systems. The Specialty Services segment refers to infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as electric, gas, water, sewer, and telecommunications infrastructure. The company was founded by Ashken Ian Guy Handley, Lillie James E and Franklin Martin E in 1926 and is headquartered in New Brighton, MN.

APi Group Corporation

APi Group Corporation is trending after reporting strong Q3 results with increased revenue and adjusted EBITDA, leading management to raise full-year guidance and indicating confidence in its safety and building maintenance services. The company's upcoming inclusion in the S&P MidCap 400 and an announced stock split are also driving investor interest, along with strategic expansion into elevator services via acquisition. While many in the community are optimistic about its recurring revenue model, some discussions note concerns around valuation and debt.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as President Trump's new tariff threats against several European nations, linked to a demand for Greenland, have sparked significant market concern. The community is sharply divided, with many predicting a substantial downturn due to escalating trade tensions and fears of a critical shift in global alliances, while others anticipate the market will largely absorb the news, citing a persistent "buy the dip" mentality. As a tech-heavy index, QQQ faces scrutiny over how these geopolitical risks will impact a highly valued market environment amid looming retaliatory measures from Europe.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD, an inverse natural gas ETF, is trending amid a highly volatile natural gas market, fueled by sharply contrasting weather forecasts. Community discussions highlight the "widow maker" nature of natural gas trades, with participants split between anticipating a "torch fest" for KOLD or a "polar vortex" that would send natural gas prices higher.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to the recent Saudi FDA approval of its Anktiva therapy for lung and bladder cancer, a move widely seen as a significant global validation for its "chemo-free" approach. The community is buzzing with optimism about the potential paradigm shift in oncology and is anticipating a substantial short squeeze, fueled by high short interest and continuous active engagement from the company's chairman on social media regarding ongoing regulatory discussions. Investors are closely monitoring for further updates from leadership and potential partnerships, expecting a re-evaluation of the company's market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cogent Biosciences (NASDAQ:COGT) Shares Up 7.1% - Still a Buy?

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 7.1% - Still a Buy...

Voya Investment Management LLC Increases Stock Position in Cogent Biosciences, Inc. $COGT

Voya Investment Management LLC increased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 110.0% during the 3rd quarter, according to its most recent filing with the...

Best Biotech Stocks To Follow Today - December 31st

Abivax, Danaher, and Cogent Biosciences are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and...

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling...

Evan Kearns Sells 65,000 Shares of Cogent Biosciences (NASDAQ:COGT) Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The shares were sold at an average...

Insider Selling: Cogent Biosciences (NASDAQ:COGT) Insider Sells 65,000 Shares of Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an average...

Cogent Biosciences (NASDAQ:COGT) Insider John Edward Robinson Sells 90,000 Shares

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider John Edward Robinson sold 90,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an...

Cogent Biosciences (NASDAQ:COGT) Insider Sells $3,198,245.40 in Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Jessica Sachs sold 82,642 shares of the company's stock in a transaction on Friday, December 26th. The stock was sold at an average...

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen analysts that are covering the firm, Marketbeat Ratings reports. One...

Squarepoint Ops LLC Purchases Shares of 101,518 Cogent Biosciences, Inc. $COGT

Squarepoint Ops LLC acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the...

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

COGT
Cogent Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COGT News

COGTCogent Biosciences Inc